Protagonist Therapeutics, Inc. (PTGX) Dividend History
Income profile from 2014 to 2025 with payout safety and yield-on-cost trend
PTGX Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
PTGX Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
PTGX Dividend History
No dividend payment history available
Get PTGX's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Protagonist Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
PTGX does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, PTGX returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 165.7%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $96,461 today.
PTGX Annual Dividend History (2014–2025)
12 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-2.05 | — | — | — |
| 2024 | $0.00 | — | 0 | $4.23 | — | — | — |
| 2023 | $0.00 | — | 0 | $-1.39 | — | — | — |
| 2022 | $0.00 | — | 0 | $-2.52 | — | — | — |
| 2021 | $0.00 | — | 0 | $-2.65 | — | — | — |
| 2020 | $0.00 | — | 0 | $-1.92 | — | — | — |
| 2019 | $0.00 | — | 0 | $-2.98 | — | — | — |
| 2018 | $0.00 | — | 0 | $-1.74 | — | — | — |
| 2017 | $0.00 | — | 0 | $-2.09 | — | — | — |
| 2016 | $0.00 | — | 0 | $-5.72 | — | — | — |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PTGX — Frequently Asked Questions
Quick answers to the most common questions about buying PTGX stock.
How much dividend does PTGX pay per share?
Protagonist Therapeutics, Inc. (PTGX) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is PTGX's next ex-dividend date?
PTGX's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. PTGX typically pays dividends quarterly.
Is PTGX's dividend safe?
PTGX's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has PTGX increased its dividend?
PTGX has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does PTGX pay dividends?
Protagonist Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 11+ years from 2014 to 2025.
How much would $10,000 invested in PTGX grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in PTGX five years ago would be worth approximately $26,574 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is PTGX's yield on cost for long-term holders?
PTGX's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.